|Dr. Richard A. B. Stewart||Exec. Chairman||699.48k||N/A||1959|
|Mr. John A. Bencich||CEO & Director||620.52k||N/A||1977|
|Dr. Cindy Jacobs||Pres, Chief Medical Officer & Director||579.81k||N/A||1958|
|Mr. Jerry Wan||Sr. Director of Accounting Operations & Principal Accounting Officer||N/A||N/A||N/A|
|Dr. Anthony Clark||Chief Scientific Officer||N/A||N/A||1956|
|Ms. Jaime Xinos||Exec. VP of Commercial||N/A||N/A||N/A|
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
Achieve Life Sciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.